Masimo Corporation Peer Comparison
Metric | Value | Ranking | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $9.6 Billion | 5/13 | DXCM $32.8B |
PODD $19.6B |
SWAV $12.6B |
PEN $10.2B |
MASI $9.6B |
GKOS $7.9B |
INSP $5.6B |
NARI $4.7B |
LIVN $2.6B |
TMDX $2.3B |
TNDM $2.2B |
NUVA $2.1B |
CNMD $1.9B |
Gross Margin | 52% | 12/13 | PODD 100% |
SWAV 87% |
NARI 87% |
INSP 84% |
GKOS 77% |
NUVA 72% |
LIVN 71% |
PEN 67% |
DXCM 60% |
CNMD 57% |
TMDX 56% |
MASI 52% |
TNDM 34% |
Profit Margin | 2% | 9/13 | SWAV 25% |
PODD 21% |
CNMD 15% |
DXCM 14% |
LIVN 10% |
PEN 10% |
INSP 9% |
TMDX 4% |
MASI 2% |
NUVA 2% |
TNDM -6% |
NARI -12% |
GKOS -22% |
EBITDA margin | -12% | 12/13 | PODD 24% |
LIVN 23% |
CNMD 21% |
NUVA 19% |
SWAV 19% |
DXCM 15% |
PEN 15% |
TMDX 8% |
INSP 7% |
NARI -5% |
TNDM -7% |
MASI -12% |
GKOS -26% |
Quarterly Revenue | $504.6 Million | 2/13 | DXCM $994.2M |
MASI $504.6M |
PODD $372.6M |
TNDM $363.3M |
LIVN $318.1M |
NUVA $317.8M |
CNMD $316.7M |
PEN $301.0M |
SWAV $218.8M |
INSP $203.2M |
NARI $153.4M |
TMDX $108.8M |
GKOS $96.7M |
Quarterly Earnings | $9.8 Million | 8/13 | DXCM $134.6M |
PODD $77.5M |
SWAV $55.3M |
CNMD $49.0M |
LIVN $33.0M |
PEN $29.5M |
INSP $18.5M |
MASI $9.8M |
NUVA $7.4M |
TMDX $4.2M |
NARI -$18.4M |
GKOS -$21.4M |
TNDM -$23.3M |
Quarterly Free Cash Flow | $33.0 Million | 6/13 | DXCM $88.3M |
PODD $76.1M |
PEN $51.0M |
CNMD $47.8M |
INSP $44.3M |
MASI $33.0M |
LIVN $32.8M |
SWAV $27.5M |
TNDM $21.5M |
NUVA -$495,000 |
NARI -$995,000 |
GKOS -$11.0M |
TMDX -$41.3M |
Trailing 4 Quarters Revenue | $2.0 Billion | 2/13 | DXCM $4.0B |
MASI $2.0B |
PODD $1.8B |
CNMD $1.3B |
LIVN $1.2B |
NUVA $1.2B |
PEN $1.2B |
TNDM $973.7M |
SWAV $788.0M |
INSP $755.6M |
NARI $574.5M |
TMDX $401.1M |
GKOS $360.3M |
Trailing 4 Quarters Earnings | $78.7 Million | 5/13 | DXCM $994.2M |
MASI $504.6M |
PODD $372.6M |
TNDM $363.3M |
LIVN $318.1M |
NUVA $317.8M |
CNMD $316.7M |
PEN $301.0M |
SWAV $218.8M |
INSP $203.2M |
NARI $153.4M |
TMDX $108.8M |
GKOS $96.7M |
Quarterly Earnings Growth | -8% | 12/13 | NUVA 925% |
LIVN 550% |
INSP 317% |
PEN 220% |
CNMD 209% |
TMDX 117% |
PODD 49% |
SWAV 41% |
GKOS 30% |
TNDM 29% |
DXCM 12% |
MASI -8% |
NARI -681% |
Annual Earnings Growth | 36% | 7/13 | LIVN 737% |
PODD 215% |
TMDX 215% |
INSP 174% |
CNMD 131% |
DXCM 45% |
MASI 36% |
TNDM 10% |
GKOS -16% |
PEN -48% |
NUVA -50% |
SWAV -65% |
NARI -934% |
Quarterly Revenue Growth | 5% | 9/13 | TNDM 96% |
TMDX 64% |
SWAV 36% |
INSP 33% |
GKOS 24% |
NARI 21% |
LIVN 11% |
PEN 11% |
MASI 5% |
CNMD 4% |
DXCM 2% |
NUVA 2% |
PODD -14% |
Annual Revenue Growth | 11% | 8/13 | TMDX 79% |
SWAV 33% |
TNDM 26% |
INSP 25% |
NARI 19% |
GKOS 13% |
PODD 12% |
MASI 11% |
DXCM 10% |
PEN 10% |
LIVN 6% |
NUVA 4% |
CNMD 2% |
Cash On Hand | $158.5 Million | 7/13 | PODD $902.6M |
DXCM $621.2M |
LIVN $346.4M |
TMDX $330.1M |
SWAV $281.7M |
PEN $280.5M |
MASI $158.5M |
INSP $147.5M |
GKOS $100.1M |
NUVA $80.7M |
TNDM $49.0M |
NARI $41.1M |
CNMD $38.5M |
Short Term Debt | $61.9 Million | 2/13 | NUVA $360.8M |
MASI $61.9M |
PODD $42.0M |
DXCM $22.3M |
LIVN $22.0M |
TNDM $18.0M |
PEN $14.5M |
SWAV $3.7M |
TMDX $2.5M |
NARI $1.6M |
CNMD $717,000 |
INSP $109,000 |
GKOS -$0 |
Long Term Debt | $733.2 Million | 5/13 | DXCM $2.5B |
PODD $1.4B |
CNMD $940.1M |
SWAV $773.1M |
MASI $733.2M |
LIVN $604.3M |
NUVA $545.4M |
TMDX $508.5M |
TNDM $457.9M |
PEN $212.2M |
GKOS $157.1M |
NARI $31.1M |
INSP $25.2M |
PE | 122.12 | 3/13 | PEN 296.68 |
INSP 169.57 |
MASI 122.12 |
LIVN 109.24 |
SWAV 76.87 |
NUVA 73.28 |
TMDX 70.04 |
DXCM 48.12 |
PODD 46.59 |
CNMD 14.66 |
GKOS -1.00 |
TNDM -1.00 |
NARI -1.00 |
PS | 4.71 | 9/13 | GKOS 21.98 |
SWAV 15.95 |
PODD 10.82 |
PEN 8.81 |
DXCM 8.29 |
NARI 8.15 |
INSP 7.42 |
TMDX 5.70 |
MASI 4.71 |
TNDM 2.26 |
LIVN 2.08 |
NUVA 1.70 |
CNMD 1.50 |
PB | 6.57 | 10/13 | PODD 17.54 |
SWAV 16.72 |
DXCM 16.55 |
GKOS 11.85 |
TMDX 10.89 |
NARI 10.77 |
PEN 9.28 |
TNDM 9.27 |
INSP 8.05 |
MASI 6.57 |
NUVA 2.34 |
CNMD 2.07 |
LIVN 1.98 |
PC | 60.64 | 3/13 | NARI 113.76 |
GKOS 79.09 |
MASI 60.64 |
DXCM 52.74 |
CNMD 50.19 |
TNDM 44.92 |
SWAV 44.62 |
INSP 37.99 |
PEN 36.54 |
NUVA 25.83 |
PODD 21.72 |
LIVN 7.47 |
TMDX 6.92 |
Liabilities to Equity | 1.11 | 8/13 | TNDM 3.03 |
TMDX 2.74 |
DXCM 2.21 |
PODD 1.71 |
CNMD 1.48 |
NUVA 1.34 |
SWAV 1.19 |
MASI 1.11 |
LIVN 0.93 |
NARI 0.60 |
GKOS 0.39 |
PEN 0.34 |
INSP 0.14 |
ROA | 0.03 | 7/13 | PODD 14% | DXCM 11% | SWAV 10% | CNMD 6% | INSP 4% | TMDX 4% | MASI 3% | PEN 2% | LIVN 1% | NUVA 1% | NARI -11% | TNDM -13% | GKOS -16% |
ROE | 0.05 | 6/13 | PODD 38% |
DXCM 34% |
SWAV 22% |
TMDX 16% |
CNMD 14% |
MASI 5% |
INSP 5% |
NUVA 3% |
PEN 3% |
LIVN 2% |
NARI -18% |
GKOS -22% |
TNDM -53% |
Current Ratio | 1.90 | 6/13 | INSP 7.99 |
PEN 3.95 |
GKOS 3.59 |
NARI 2.66 |
LIVN 2.08 |
MASI 1.90 |
SWAV 1.84 |
NUVA 1.75 |
CNMD 1.67 |
PODD 1.59 |
DXCM 1.45 |
TMDX 1.36 |
TNDM 1.33 |
Quick Ratio | 0.10 | 11/13 | PEN 296.68 |
INSP 169.57 |
MASI 122.12 |
LIVN 109.24 |
SWAV 76.87 |
NUVA 73.28 |
TMDX 70.04 |
DXCM 48.12 |
PODD 46.59 |
CNMD 14.66 |
GKOS -1.00 |
TNDM -1.00 |
NARI -1.00 |
Long Term Debt to Equity | 0.50 | 8/13 | TMDX} 2.42 |
TNDM} 1.93 |
DXCM} 1.27 |
PODD} 1.21 |
SWAV} 1.03 |
CNMD} 1.01 |
NUVA} 0.61 |
MASI} 0.50 |
LIVN} 0.46 |
GKOS} 0.24 |
PEN} 0.19 |
NARI} 0.07 |
INSP} 0.04 |
Debt to Equity | 0.50 | 8/13 | TMDX 2.42 |
TNDM 2.00 |
DXCM 1.28 |
PODD 1.25 |
SWAV 1.03 |
NUVA 1.02 |
CNMD 1.01 |
MASI 0.50 |
LIVN 0.48 |
GKOS 0.24 |
PEN 0.21 |
NARI 0.08 |
INSP 0.04 |
Burn Rate | 4.53 | 2/13 | TMDX 19.69 |
MASI 4.53 |
GKOS 3.62 |
NARI 2.06 |
TNDM 1.06 |
NUVA 0.77 |
CNMD -3.43 |
INSP -8.45 |
SWAV -11.98 |
PEN -16.10 |
DXCM -21.72 |
PODD -70.80 |
LIVN -105.16 |
Cash to Cap | 0.02 | 7/13 | TMDX 0.14 |
LIVN 0.13 |
PODD 0.05 |
NUVA 0.04 |
PEN 0.03 |
INSP 0.03 |
MASI 0.02 |
TNDM 0.02 |
DXCM 0.02 |
CNMD 0.02 |
SWAV 0.02 |
GKOS 0.01 |
NARI 0.01 |
CCR | 3.37 | 1/13 | MASI 3.37 |
INSP 2.39 |
PEN 1.73 |
LIVN 1.00 |
PODD 0.98 |
CNMD 0.98 |
DXCM 0.66 |
GKOS 0.52 |
SWAV 0.50 |
NARI 0.05 |
NUVA -0.07 |
TNDM -0.93 |
TMDX -9.81 |
EV to EBITDA | -170.90 | 11/13 | INSP} 382.86 |
SWAV} 308.03 |
TMDX} 289.17 |
PEN} 230.35 |
PODD} 228.20 |
DXCM} 228.10 |
NUVA} 47.54 |
CNMD} 43.12 |
LIVN} 39.04 |
TNDM} -100.78 |
MASI} -170.90 |
GKOS} -323.48 |
NARI} -647.99 |
EV to Revenue | 4.99 | 9/13 | GKOS 22.14 |
SWAV 16.58 |
PODD 11.09 |
DXCM 8.77 |
PEN 8.76 |
NARI 8.13 |
INSP 7.25 |
TMDX 6.14 |
MASI 4.99 |
TNDM 2.70 |
NUVA 2.37 |
LIVN 2.31 |
CNMD 2.20 |